Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06402747
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-26
Brief Title:
Clopidogrel Versus Cilostazol on Vessels
Sponsor:
Seoul National University Bundang Hospital
Organization:
Seoul National University Bundang Hospital
Study Overview
Official Title:
Comparing Clopidogrel and Cilostazol in Type 2 Diabetes Patients With Carotid Atherosclerosis
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Diabetes is an increasing cause of atherosclerotic and cardiovascular illnesses in South Korea The clinical application of ultrasound for measuring carotid intima-media thickness which helps in early detection and surveillance of atherosclerosis is advancing Due to lifestyle changes and an aging population Koreans especially diabetics are developing more vascular diseases and are at higher risk for peripheral vascular disorders Diabetics with lower limb peripheral artery disease require effective therapy to avoid major complications and a reduced quality of life Although licensed for symptom control Clopidogrel and Cilostazol have not yet been established for primary prevention of cardiovascular risks These medications will be evaluated for their potential as primary preventive agents against cardiovascular disease in type 2 diabetes patients The goal of this research is to investigate the efficacy of Cilostazol and Clopidogrel in inhibiting the progression of carotid atherosclerosis and to evaluate their influence on hemorheological changes in individuals with Type 2 diabetes The goal of this research is to investigate the efficacy of Cilostazol and Clopidogrel in inhibiting the progression of carotid atherosclerosis and evaluating their influence on alterations in blood flow among individuals with Type 2 diabetes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None